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Multiple sclerosis and other demyelination diseases are
associated with positive (gain of function), negative (loss
of function), and paroxysmal (sudden and short duration)
symptoms. These symptoms occur in a remarkable diver-
sity of modalities including prolonged or, in the case of
paroxysmal symptoms, brief episodes of pain, paresthesia
(numbness), dysarthria (difficulty speaking), weakness,
muscle spasms, etc. [1]. Using computational modeling,
we have recently established the mechanisms underlying
four distinct phases of action potential (AP) firing asso-
ciated with demyelination and secondary compensatory
changes [2]. Transitions in axonal excitability caused by
varying the ratio of gNa and gL indicate that a single
mechanism controlling conductance balance is sufficient
to explain normal spiking, failed conduction, after-
discharge (AD) and spontaneous activity, and can thus
account for the full range of negative, paroxysmal and
tonic positive symptoms, respectively. Positive symptoms
are thought to arise from ectopic spike discharge, but the
biophysical mechanisms responsible for the abrupt onset
and self limiting duration of paroxysmal AD are poorly
understood and were thus a particular area of focus.
We used two types of complementary models. The first
was a Hodgkin-Huxley (HH), multi-compartment model
of a focally demyelinated axon created using the NEU-
RON Simulator (http://www.neuron.yale.edu/neuron,
[3]) based on a geometrically simplified model to first
understand the behaviors of electrical conductances. The
second was a modified Morris-Lecar, single compartment
model [4] that has been described in detail [5]. We
explored this model with phase-plane and bifurcation
analysis using XPPAUT in order to rigorously character-
ize the dynamical mechanisms underlying phenomena
identified in the HH model.
In both models, the paroxysmal AD can only occur
when the system is bi-stable and initiation occurs when a
perturbation abruptly switches the system between
attractor states. Termination of paroxysms occurs when
internal dynamics shift the basins of attraction until the
system falls back to its original stable state. Temporal
summation and refractoriness can also be simply
explained within this framework. Disruption of the oligo-
dendrocytes that form the myelin sheaths may lead to
abnormal electrolyte homeostasis in the vicinity of the
denuded axon. Our models indicate that the pathological
accumulation of Na
+ or K
+ can influence the duration of
paroxysmal firing by acting as an additional, ultra-slow
feedback mechanism in the dynamical system. As such, a
naked patch of previously myelinated axonal membrane
becomes capable of competing with the same neuron’s
soma for the initiation of burst firing patterns and inter-
feres with normal firing patterns. Although not biologi-
cally detailed, our modeling nonetheless provides
significant insight into how biologically realistic mechan-
isms can interact to produce neuronal discharges as well
as other abnormal firing characteristics in the course of
demyelination.
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